TY - JOUR
T1 - Use of chimeric antigen receptor T cells in allogeneic hematopoietic stem cell transplantation
AU - Liu, Jun
AU - Zhang, Xi
AU - Zhong, Jiang F.
AU - Zhang, Cheng
N1 - Publisher Copyright:
© 2019 2018 Future Medicine Ltd.
PY - 2019/1
Y1 - 2019/1
KW - CAR-T cells
KW - acute lymphoblastic leukemia
KW - acute myeloid leukemia
KW - allogeneic CAR-T cells
KW - allogeneic hematopoietic stem cell transplantation
KW - conditioning regimen
KW - donor-derived CAR-T cells
KW - hematological malignancies
KW - preventive infusion
KW - Graft vs Leukemia Effect/immunology
KW - T-Lymphocytes/immunology
KW - Humans
KW - Immune Tolerance
KW - Leukemia, Myeloid, Acute/therapy
KW - Combined Modality Therapy
KW - Transplantation, Homologous
KW - Neoplasm, Residual
KW - Animals
KW - Hematopoietic Stem Cell Transplantation/methods
KW - Immunotherapy, Adoptive/methods
KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy
KW - Transplantation Conditioning
KW - Receptors, Chimeric Antigen/genetics
KW - Graft vs Host Disease/immunology
UR - http://www.scopus.com/inward/record.url?scp=85058139444&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058139444&partnerID=8YFLogxK
U2 - 10.2217/imt-2018-0089
DO - 10.2217/imt-2018-0089
M3 - Article
C2 - 30702011
AN - SCOPUS:85058139444
SN - 1750-743X
VL - 11
SP - 37
EP - 44
JO - Immunotherapy
JF - Immunotherapy
IS - 1
ER -